JP2019514895A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019514895A5 JP2019514895A5 JP2018555682A JP2018555682A JP2019514895A5 JP 2019514895 A5 JP2019514895 A5 JP 2019514895A5 JP 2018555682 A JP2018555682 A JP 2018555682A JP 2018555682 A JP2018555682 A JP 2018555682A JP 2019514895 A5 JP2019514895 A5 JP 2019514895A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence
- epitope
- peptide
- cst
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 22
- 150000001413 amino acids Chemical class 0.000 claims 16
- 239000000427 antigen Substances 0.000 claims 10
- 102000036639 antigens Human genes 0.000 claims 10
- 108091007433 antigens Proteins 0.000 claims 10
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 5
- 238000000034 method Methods 0.000 claims 4
- 210000004027 cell Anatomy 0.000 claims 3
- 230000002163 immunogen Effects 0.000 claims 3
- 101710197241 Accessory gland-specific peptide 70A Proteins 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 201000006417 multiple sclerosis Diseases 0.000 claims 2
- 108010002350 Interleukin-2 Proteins 0.000 claims 1
- 230000001461 cytolytic effect Effects 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 210000000581 natural killer T-cell Anatomy 0.000 claims 1
- 210000004976 peripheral blood cell Anatomy 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021200876A JP2022022423A (ja) | 2016-04-19 | 2021-12-10 | 新規な免疫原性ＣＤ１ｄ結合ペプチド |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16166054 | 2016-04-19 | ||
| EP16166054.3 | 2016-04-19 | ||
| PCT/EP2017/059302 WO2017182528A1 (en) | 2016-04-19 | 2017-04-19 | Novel immunogenic cd1d binding peptides |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021200876A Division JP2022022423A (ja) | 2016-04-19 | 2021-12-10 | 新規な免疫原性ＣＤ１ｄ結合ペプチド |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019514895A JP2019514895A (ja) | 2019-06-06 |
| JP2019514895A5 true JP2019514895A5 (enExample) | 2020-08-20 |
| JP7320947B2 JP7320947B2 (ja) | 2023-08-04 |
Family
ID=56024090
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018555682A Active JP7320947B2 (ja) | 2016-04-19 | 2017-04-19 | 新規な免疫原性ＣＤ１ｄ結合ペプチド |
| JP2021200876A Pending JP2022022423A (ja) | 2016-04-19 | 2021-12-10 | 新規な免疫原性ＣＤ１ｄ結合ペプチド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021200876A Pending JP2022022423A (ja) | 2016-04-19 | 2021-12-10 | 新規な免疫原性ＣＤ１ｄ結合ペプチド |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US11485768B2 (enExample) |
| EP (1) | EP3445390A1 (enExample) |
| JP (2) | JP7320947B2 (enExample) |
| KR (3) | KR20240015731A (enExample) |
| CN (1) | CN109069605B (enExample) |
| AU (2) | AU2017252192C1 (enExample) |
| BR (1) | BR112018071466A2 (enExample) |
| CA (1) | CA3019266A1 (enExample) |
| IL (1) | IL262286B2 (enExample) |
| RU (1) | RU2018136760A (enExample) |
| SG (1) | SG11201808710UA (enExample) |
| WO (1) | WO2017182528A1 (enExample) |
| ZA (1) | ZA201806860B (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2476435T (pt) | 2006-08-11 | 2018-03-05 | Life Sciences Res Partners Vzw | Péptidos imunogénicos e a sua utilização em distúrbios imunitários |
| CA2715611C (en) | 2008-02-14 | 2018-03-13 | Life Sciences Research Partners Vzw | Immunotherapy targeting intracellular pathogens |
| GB201309469D0 (en) | 2013-05-28 | 2013-07-10 | Imcyse Sa | Detection of CD4+ T lymphocytes |
| GB201418433D0 (en) | 2014-10-17 | 2014-12-03 | Imcyse Sa | Novel immunogenic peptides |
| US10729791B2 (en) | 2015-05-18 | 2020-08-04 | Imcyse Sa | Animal models for evaluating pharmaceutical compounds |
| EP3352782B1 (en) | 2015-09-25 | 2021-03-31 | ImCyse SA | Improved methods and compounds for eliminating immune responses to therapeutic agents |
| US20210401976A1 (en) * | 2018-11-12 | 2021-12-30 | Imcyse Sa | Immunogenic peptides with improved oxidoreductase motifs |
| WO2020229703A1 (en) | 2019-05-16 | 2020-11-19 | Imcyse Sa | Immunogenic peptides with an oxidoreductase motif comprising a modified cysteine |
| WO2021224403A1 (en) * | 2020-05-06 | 2021-11-11 | Imcyse Sa | Immunogenic peptides with new oxidoreductase motifs |
| CU20220066A7 (es) * | 2020-05-06 | 2023-06-13 | Imcyse Sa | Péptidos inmunogénicos útiles en el tratamiento de esclerosis múltiple |
| JP2023525276A (ja) * | 2020-05-06 | 2023-06-15 | アンシス・エスア | 延長された酸化還元酵素モチーフを有する免疫原性ペプチド |
| CA3182369A1 (en) | 2020-05-06 | 2021-07-22 | Imcyse Sa | Combination treatment for fumarate-related diseases |
| AR126654A1 (es) | 2021-06-29 | 2023-11-01 | Imcyse Sa | Péptidos y métodos para el tratamiento de neuromielitis óptica |
| WO2023086480A2 (en) * | 2021-11-10 | 2023-05-19 | Tscan Therapeutics, Inc. | Magea1 immunogenic peptides, binding proteins recognizing magea1 immunogenic peptides, and uses thereof |
| CN114196629B (zh) * | 2021-12-23 | 2024-02-27 | 珠海贝索细胞科学技术有限公司 | 一种高效培养nkt细胞的试剂及其应用和nkt细胞的培养方法 |
Family Cites Families (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4599231A (en) | 1984-03-09 | 1986-07-08 | Scripps Clinic And Research Foundation | Synthetic hepatitis B virus vaccine including both T cell and B cell determinants |
| WO1985004103A1 (en) | 1984-03-09 | 1985-09-26 | Scripps Clinic And Research Foundation | Synthetic hepatitis b virus vaccine including both t cell anc b cell determinants |
| US4886782A (en) | 1987-02-26 | 1989-12-12 | The United States Of America As Represented By The Department Of Health And Human Services | Malarial immunogen |
| US5433948A (en) | 1990-02-13 | 1995-07-18 | Thomas; Wayne R. | Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
| EP0550599B1 (en) | 1990-09-27 | 2003-04-23 | Tripep AB | Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus |
| EP0623168B1 (en) | 1991-10-16 | 2009-09-30 | Merck Patent GmbH | T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
| US7252829B1 (en) | 1998-06-17 | 2007-08-07 | Idm Pharma, Inc. | HLA binding peptides and their uses |
| US5589582A (en) | 1992-10-27 | 1996-12-31 | Biotransplant, Inc. | Polynucleotides en coding porcine cytokines |
| US5633234A (en) | 1993-01-22 | 1997-05-27 | The Johns Hopkins University | Lysosomal targeting of immunogens |
| US5824315A (en) | 1993-10-25 | 1998-10-20 | Anergen, Inc. | Binding affinity of antigenic peptides for MHC molecules |
| US8791237B2 (en) | 1994-11-08 | 2014-07-29 | The Trustees Of The University Of Pennsylvania | Compositions and methods for treatment of non-hodgkins lymphoma |
| US7157089B1 (en) | 1996-11-26 | 2007-01-02 | Stressgen Biotechnologies Corporation | Immune responses using compositions containing stress proteins |
| AU1124499A (en) | 1997-10-28 | 1999-05-17 | Maxygen, Inc. | Human papillomavirus vectors |
| NO315238B1 (no) | 1998-05-08 | 2003-08-04 | Gemvax As | Peptider som stammer fra leserammeforskyvingsmutasjoner i TBF<beta>II- eller BAX-genet, og farmasöytiske sammensetninger inneholdende disse,nukleinsyresekvenser som koder for slike peptider, plasmider og virusvektoreromfattende slikenukleinsy |
| US20030152581A1 (en) | 1998-07-30 | 2003-08-14 | Jean-Marie Saint-Remy | Compound and method for the prevention and/or the treatment of allergy |
| AR020102A1 (es) | 1998-07-30 | 2002-04-10 | Ucb Sa | Compuesto para la prevencion y/o tratamiento de la alergia; composicion farmaceutica, composicion cosmetica, composicion en forma de bebida, alimento y/oalimento para animales domesticos que lo comprende y uso de dicho compuesto o dicha composicion farmaceutica para la fabricacion de un alimento |
| CA2350911A1 (en) | 1998-11-16 | 2000-05-25 | Board Of Regents, The University Of Texas System | Hiv-specific t-cell induction |
| GB0006437D0 (en) | 2000-03-17 | 2000-05-10 | Leuven Res & Dev Vzw | Compounds for the modulation of allergen sensitivity by antigens sharing T cell epitopes with allergens |
| AU2001254620A1 (en) | 2000-04-28 | 2001-11-12 | Novozymes A/S | Lipolytic enzyme variant |
| AU2001272491A1 (en) | 2000-06-26 | 2002-01-08 | Smithkline Beecham Biologicals (S.A.) | Triple fusion proteins comprising ubiquitin fused between thioredoxin and a polypeptide of interest |
| US7049413B2 (en) | 2001-05-18 | 2006-05-23 | Ludwig Institute For Cancer Research | MAGE-A3 peptides presented by HLA class II molecules |
| US20040173778A1 (en) | 2001-05-30 | 2004-09-09 | Roncarolo Maria Grazia | Ex-vivo isolated cd25+cd4+ t cells with immunosuppressive activity and uses thereof |
| EP1432738B1 (en) | 2001-10-03 | 2009-03-04 | Unilever N.V. | Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them |
| WO2003072731A2 (en) | 2002-02-21 | 2003-09-04 | Apovia, Inc. | STABILIZED HBc CHIMER PARTICLES HAVING MENINGOCCOCAL IMMUNOGENS |
| US20100183652A1 (en) | 2002-02-21 | 2010-07-22 | Mark Page | STABILIZED HBc CHIMER PARTICLES AS THERAPEUTIC VACCINE FOR CHRONIC HEPATITIS |
| AU2003254950A1 (en) | 2002-08-26 | 2004-03-11 | Kirin Beer Kabushiki Kaisha | Peptides and drugs containing the same |
| CN103073620B (zh) | 2002-09-12 | 2014-12-10 | 肿瘤疗法科学股份有限公司 | Kdr肽和包括该肽的疫苗 |
| EP1556072B1 (en) * | 2002-09-17 | 2010-05-19 | Antigen Express, Inc. | Ii-KEY/ANTIGENIC EPITOPE HYBRID PEPTIDE VACCINES |
| JP2004147649A (ja) | 2002-10-11 | 2004-05-27 | Kumamoto Technology & Industry Foundation | 頭頚部癌の抗原 |
| WO2005012502A2 (en) | 2003-03-28 | 2005-02-10 | Idm Pharma, Inc. | Methods of identifying optimal variants of peptide epitopes |
| US7651855B2 (en) | 2003-04-17 | 2010-01-26 | The Trustees Of The University Of Pennsylvania | Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses |
| GB0324265D0 (en) | 2003-10-16 | 2003-11-19 | Medical Res Council | Peptide |
| WO2005042575A2 (en) | 2003-10-30 | 2005-05-12 | Pharmexa A/S | Method for down-regulation of vegf |
| JP2008044848A (ja) | 2004-11-30 | 2008-02-28 | Univ Kurume | Ｈｌａ−ａ２４拘束性腫瘍抗原ペプチド |
| US8252893B2 (en) | 2005-01-31 | 2012-08-28 | Board Of Trustees Of The University Of Arkansas | CD8 T cell epitopes in HPV 16 E6 and E7 proteins and uses thereof |
| US10183986B2 (en) | 2005-12-15 | 2019-01-22 | Industrial Technology Research Institute | Trimeric collagen scaffold antibodies |
| GB0603081D0 (en) | 2006-02-15 | 2006-03-29 | Dynal Biotech Asa Oslo | Method |
| FR2898275B1 (fr) | 2006-03-10 | 2012-12-14 | Genethon | Cellules t regulatrices cd4+cd25+specifiques pour la greffe de cellules hematopoietiques et la tolerance immunitaire |
| WO2007135684A2 (en) | 2006-05-22 | 2007-11-29 | Hadasit Medical Research Services & Development Limited | Method of treatment of anti-cd4 autoimmunity |
| PT2476435T (pt) | 2006-08-11 | 2018-03-05 | Life Sciences Res Partners Vzw | Péptidos imunogénicos e a sua utilização em distúrbios imunitários |
| EP2158211B1 (en) | 2007-05-31 | 2016-08-10 | Medigene AG | Mutated structural protein of a parvovirus |
| CA2700618A1 (en) | 2007-09-27 | 2009-04-02 | The Board Of Trustees Of The University Of Arkansas | Inhibition of dendritic cell-driven regulatory t cell activation and potentiation of tumor antigen-specific t cell responses by interleukin-15 and map kinase inhibitor |
| US9248171B2 (en) | 2008-02-14 | 2016-02-02 | Imcyse Sa | Immunogenic peptides and their use in transplantation |
| AU2009214041A1 (en) | 2008-02-14 | 2009-08-20 | Katholieke Universiteit Leuven | CD4+ T-cells with cytolytic properties |
| WO2009101206A2 (en) | 2008-02-14 | 2009-08-20 | Life Sciences Research Partners Vzw | Strategies to prevent and/or treat immune responses to soluble allofactors |
| CA2715611C (en) | 2008-02-14 | 2018-03-13 | Life Sciences Research Partners Vzw | Immunotherapy targeting intracellular pathogens |
| US8999346B2 (en) | 2008-02-14 | 2015-04-07 | Life Sciences Research Partners Vzw | Immunogenic control of tumours and tumour cells |
| WO2009101204A2 (en) | 2008-02-14 | 2009-08-20 | Life Sciences Research Partners Vzw | Elimination of immune responses to viral vectors |
| WO2009106073A2 (en) | 2008-02-28 | 2009-09-03 | Dako Denmark A/S | Mhc multimers in borrelia diagnostics and disease |
| KR101022649B1 (ko) | 2008-08-07 | 2011-03-22 | 삼성모바일디스플레이주식회사 | 헤테로고리 화합물 및 이를 이용한 유기 전계 발광 장치 |
| US20110318380A1 (en) | 2008-10-01 | 2011-12-29 | Dako Denmark A/S | MHC Multimers in Cancer Vaccines and Immune Monitoring |
| US8647879B2 (en) * | 2009-08-14 | 2014-02-11 | Polytechnic Institute Of Nyu | Peptide probe for rapid and specific detection of β-amyloid aggregation |
| CN103002909B (zh) | 2010-03-29 | 2016-06-29 | 国家科学研究中心 | 包含含有至少一个cxxc基序的多肽和异源抗原的药物组合物及其用途 |
| RU2615460C2 (ru) * | 2010-11-25 | 2017-04-04 | Имнейт Сарл | Иммуногенные пептиды для применения в профилактике и/или лечении инфекционных заболеваний, аутоиммунных заболеваний, иммунных ответов на аллогенные факторы, аллергических заболеваний, опухолей, отторжения трансплантата и иммунных ответов против вирусных векторов. используемых для генной терапии или генной вакцинации |
| DK2643346T3 (en) * | 2010-11-25 | 2018-10-29 | Imnate Sarl | MODULATION OF ANTIGEN IMMUNOGENICITY BY ADDITION OF EPITOPES RECOGNIZED BY NKT CELLS |
| GB201201511D0 (en) | 2012-01-30 | 2012-03-14 | Univ Leuven Kath | Modified epitopes for boosting CD4+ T-cell responses |
| CN104271148A (zh) | 2012-02-15 | 2015-01-07 | 洛桑聚合联合学院 | 红细胞结合性治疗剂 |
| AU2013255888A1 (en) * | 2012-04-30 | 2014-10-23 | Imcyse Sa | Methods for induction of antigen-specific regulatory T cells |
| US9603948B2 (en) * | 2012-10-11 | 2017-03-28 | Uti Limited Partnership | Methods and compositions for treating multiple sclerosis and related disorders |
| GB201309469D0 (en) | 2013-05-28 | 2013-07-10 | Imcyse Sa | Detection of CD4+ T lymphocytes |
| GB201319160D0 (en) | 2013-10-30 | 2013-12-11 | Imcyse Sa | Methods for induction of antigen-specific regulatory t cells |
| GB201418433D0 (en) * | 2014-10-17 | 2014-12-03 | Imcyse Sa | Novel immunogenic peptides |
| US10729791B2 (en) | 2015-05-18 | 2020-08-04 | Imcyse Sa | Animal models for evaluating pharmaceutical compounds |
| EP3352782B1 (en) | 2015-09-25 | 2021-03-31 | ImCyse SA | Improved methods and compounds for eliminating immune responses to therapeutic agents |
-
2017
- 2017-04-19 KR KR1020247002453A patent/KR20240015731A/ko not_active Withdrawn
- 2017-04-19 CN CN201780024518.0A patent/CN109069605B/zh active Active
- 2017-04-19 WO PCT/EP2017/059302 patent/WO2017182528A1/en not_active Ceased
- 2017-04-19 BR BR112018071466-6A patent/BR112018071466A2/pt unknown
- 2017-04-19 US US16/091,549 patent/US11485768B2/en active Active
- 2017-04-19 CA CA3019266A patent/CA3019266A1/en active Pending
- 2017-04-19 KR KR1020187031509A patent/KR20180134935A/ko not_active Ceased
- 2017-04-19 AU AU2017252192A patent/AU2017252192C1/en not_active Ceased
- 2017-04-19 IL IL262286A patent/IL262286B2/en unknown
- 2017-04-19 RU RU2018136760A patent/RU2018136760A/ru not_active Application Discontinuation
- 2017-04-19 JP JP2018555682A patent/JP7320947B2/ja active Active
- 2017-04-19 SG SG11201808710UA patent/SG11201808710UA/en unknown
- 2017-04-19 EP EP17721070.5A patent/EP3445390A1/en active Pending
- 2017-04-19 KR KR1020227031956A patent/KR20220132023A/ko not_active Ceased
-
2018
- 2018-10-15 ZA ZA2018/06860A patent/ZA201806860B/en unknown
-
2021
- 2021-12-10 JP JP2021200876A patent/JP2022022423A/ja active Pending
-
2022
- 2022-05-27 AU AU2022203627A patent/AU2022203627A1/en not_active Abandoned
- 2022-09-23 US US17/934,607 patent/US20230265156A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019514895A5 (enExample) | ||
| AU2019250206A1 (en) | Novel immunogenic peptides | |
| RU2018136760A (ru) | НОВЫЕ ИММУНОГЕННЫЕ CD1d-СВЯЗЫВАЮЩИЕ ПЕПТИДЫ | |
| CO2021004028A2 (es) | Proceso para la preparación de composiciones de vacunas | |
| AU2007218649B2 (en) | HLA-A*3303-restricted WT1 peptide and pharmaceutical composition comprising the same | |
| JP2007516966A5 (enExample) | ||
| AU2015257774B2 (en) | Peptide vaccine comprising mutant RAS peptide and chemotherapeutic agent | |
| RU2019126232A (ru) | Пептиды и способы для лечения диабета | |
| JP2017523184A5 (enExample) | ||
| MX377144B (es) | Nuevos peptidos y nueva combinacion de peptidos para el uso en la inmunoterapia contra el carcinoma hepatocelular (chc) y otros tipos de cancer. | |
| JP2012506411A5 (enExample) | ||
| KR20140100422A (ko) | 백신 조성물 | |
| RU2714117C2 (ru) | Пептид, полученный из gpc3, фармацевтическая композиция для лечения или предотвращения рака с его использованием, индуктор иммунитета и способ получения антиген-презентирующих клеток | |
| JP2015110588A5 (enExample) | ||
| BR112019001656A2 (pt) | composição, composição farmacêutica, vacina, método para induzir anticorpos em um indivíduo, método para tratar câncer em um paciente necessitando do mesmo e método para induzir ou melhorar a reação imune em um indivíduo necessitando do mesmo | |
| RU2010110545A (ru) | Cdh3-пептид и включающее его лекарственное средство | |
| SA521421371B1 (ar) | لقاحات الببتيد | |
| CA2840954A1 (en) | Vaccine composition for transdermal or mucosal administration | |
| WO2015140172A3 (en) | A medicament for use in a method of inducing or extending a cellular cytotoxic immune response | |
| KR20140100421A (ko) | 경피 투여용 ｗｔ1 펩티드 암 백신 테이프제 | |
| RU2018120387A (ru) | Ангиотензин в лечении состояний головного мозга | |
| FI4021487T3 (fi) | Antigeenisiä peptidejä b-solun pahanlaatuisuuden ehkäisyyn ja hoitoon | |
| RU2015134357A (ru) | Пептид | |
| RU2011120447A (ru) | Эпитопные пептиды rab6kifl/kif20a и содержащие их вакцины | |
| RU2018145945A (ru) | Пептид для лечения остеоартрита, фармацевтическая композиция, лекарственное средство, единичная дозированная форма |